文献速递瓣膜外科

经导管主动脉瓣置换术中的栓塞保护装置

Embolic protection devices for transcatheter aortic valve replacement.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

本文综述经导管主动脉瓣置换术(TAVR)围术期脑血管事件的机制及栓塞保护装置(EPD)的临床与影像学结果。已发表结果显示,EPD可能有助于减小磁共振成像上发现的围术期无症状缺血性脑病灶的体积和大小,但不能减少新发病灶和新发神经事件的发生率。EPD降低TAVR期间短暂性脑缺血发作/卒中的临床影响需进一步随机试验研究。

要点

  • EPD可能减小TAVR围术期磁共振成像上无症状缺血性脑病灶的体积和大小。
  • EPD未减少新发缺血性脑病灶及新发神经事件的发生率。
  • EPD降低TAVR期间短暂性脑缺血发作/卒中的临床影响需进一步随机试验研究。

核心结论

  • 已发表结果表明,EPD可能有助于减小磁共振成像上识别的围术期无症状缺血性脑病灶的体积和大小,但不能减少新发病灶和新发神经事件的发生率。
  • EPD在降低TAVR期间短暂性脑缺血发作/卒中数量方面的临床影响需在随机试验中进一步研究。

研究设计与样本

  • 本文为文献综述,评估TAVR期间神经事件的发生率和机制,并分析EPD使用后的临床结果和影像学发现。

主要发现

  • Embrella、TriGuard、Sentinel和Embol-X装置的临床试验旨在测试其安全性及在TAVR患者中预防神经并发症的能力。
  • 已发表结果显示,EPD可能有助于减小磁共振成像上识别的围术期无症状缺血性脑病灶的体积和大小,但不能减少新发病灶和新发神经事件的发生率。
  • TAVR后脑血管事件的原因是多因素的,选择可从EPD获益的患者对进一步改善结局、生存率和生活质量至关重要。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • EPD降低TAVR期间短暂性脑缺血发作/卒中的临床影响需在随机试验中进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transcatheter aortic valve replacement (TAVR) is a major advancement in the treatment of severe aortic valve stenosis in elderly high-risk patients. Implementing TAVR also in younger intermediate- or low-risk patients increases interest in the possibility of further lowering the risk of perioperative cerebrovascular events. To this aim, some embolic protection devices (EPDs) have been developed, some of which have already been approved for clinical use. Nevertheless, the cause of cerebrovascular events after TAVR is multifactorial, and selection of patients who would benefit from EPD is crucial to further improve outcomes, survival rate and quality of life. We reviewed the available literature in order to assess the incidence of and the mechanisms responsible for neurological events that can occur during TAVR, and we analysed clinical results and imaging findings following EPD use. Clinical trials for Embrella, TriGuard, Sentinel and Embol-X devices were designed to test their safety and their ability to prevent neurological complications in patients having TAVR. So far, published results showed that EPD may help in reducing the volume and size of periprocedural silent ischaemic brain lesions identified on magnetic resonance images but not in reducing the incidence of new lesions and new neurological events. The clinical impact of EPD in lowering the number of transient ischaemic attacks/strokes during TAVR needs to be further investigated in randomized trials.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gallo M, Putzu A, Conti M, et al. Embolic protection devices for transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2018. PMID: 29253108. doi:10.1093/ejcts/ezx457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。